SuperGen, Inc. To Present At C.E. Unterberg, Towbin Life Sciences Conference

DUBLIN, Calif., Oct. 21 /PRNewswire-FirstCall/ -- SuperGen, Inc. today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the C.E. Unterberg, Towbin Life Sciences Conference, being held at the New York Palace Hotel on Wednesday, October 26, 2005, at 11:20 a.m. ET. Dr. Manuso will provide a brief corporate overview and discuss the Company's recent progress. A live webcast of the presentation will be available on the Investor Relations section of the Company's website at http://www.supergen.com . The webcast will be archived for 90 days.

About SuperGen

Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to the acquisition, rapid development and commercialization of therapies for solid tumors, hematological malignancies and blood disorders. SuperGen's product portfolio includes Nipent(R) (pentostatin for injection); Mitomycin (generic brand of Mutamycin(R)); and SurfaceSafe(R) cleaner.

For more information about SuperGen, please visit http://www.supergen.com. Contacts: Timothy L. Enns Sharon Weinstein SuperGen, Inc. Noonan Russo Tel: (925) 560-0100 x111 Tel: (212) 845-4271 E-mail: tenns@supergen.com E-mail: sharon.weinstein@eurorscg.com

SuperGen

CONTACT: Timothy L. Enns of SuperGen, Inc., +1-925-560-0100 x111,tenns@supergen.com; or Sharon Weinstein, Noonan Russo for SuperGen,+1-212-845-4271, sharon.weinstein@eurorscg.com

Back to news